CAS 1847461-43-1

1-Methylethyl 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-4-(1-methyl-1H-indol-3-yl)-5-pyrimidinecarboxylate

CAS: 1847461-43-1

Fórmula: C₃₂H₃₉N₇O₄

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 585.6966

Ref: IN-DA01K3KJ

Mobocertinib

CAS: 1847461-43-1

Mobocertinib

Pureza: ≥98%

Peso molecular: 585.7g/mol

Ref: 54-BUP13219

Mobocertinib

CAS: 1847461-43-1

Mobocertinib

Pureza: 99%

Peso molecular: 585.71g/mol

Ref: 54-OR1025535

Mobocertinib (TAK788)

CAS: 1847461-43-1

Fórmula: C₃₂H₃₉N₇O₄

Peso molecular: 585.71

Ref: 4Z-K-031054

Mobocertinib

CAS: 1847461-43-1

Mobocertinib (tak788) is a potent inhibitor of epidermal growth factor receptor (EGFR) and an antineoplastic agent

Fórmula: C₃₂H₃₉N₇O₄

Pureza: 99.47% - 99.97%

Cor e Forma: Solid

Peso molecular: 585.7

Ref: TM-T8151

Mobocertinib

CAS: 1847461-43-1

Mobocertinib is a small-molecule tyrosine kinase inhibitor, which is a targeted therapy derived from synthetic chemistry. It primarily exerts its effect by selectively inhibiting the activity of epidermal growth factor receptor (EGFR) with exon 20 insertion mutations. These mutations, which occur in the kinase domain of the EGFR, lead to aberrant activation of signaling pathways that promote oncogenic processes.

Fórmula: C₃₂H₃₉N₇O₄

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 585.7 g/mol

Ref: 3D-XYC46143